Prior Authorization Reform: A Win for Access — and a Wake-Up Call for Oversight

On June 23, 2025, the U.S. Department of Health and Human Services (HHS) announced a sweeping industry pledge to reform the prior authorization process — a move that could impact over 250 million Americans across Medicare Advantage, Medicaid managed care, and commercial plans.

The reforms, backed by major insurers like Aetna, UnitedHealthcare, and Kaiser Permanente, promise to:

• Reduce the number of services requiring prior authorization by 2026
• Standardize electronic submissions using FHIR-based APIs
• Expand real-time approvals by 2027
• Ensure clinical review of all denials

At first glance, this is a long-overdue win for patients and providers. But beneath the celebration lies a new challenge: as the gates open wider, who’s watching what comes through?

The Risk: Looser Controls, Higher Exposure

LinkedIn is already buzzing with concern — and rightly so. While the reforms aim to reduce administrative burden and delays in care, they also weaken a key checkpoint in the payment integrity chain. Prior authorization has long served as a front-line filter for inappropriate, duplicative, or low-value services.

With that filter now being loosened, the burden of oversight shifts downstream — from pre-service review to post-service detection.

Why Oversight and Detection Matter More Than Ever

This is where health systems, payers, and audit vendors must pivot fast. The reforms don’t eliminate risk — they redistribute it. And without robust post-payment analytics, the system could see:

• Spikes in unnecessary procedures slipping through
• Increased upcoding and DRG creep
• Exploitation of real-time approvals by bad actors
• Documentation gaps that go unchecked until it’s too late

The Solution: Smart Surveillance, Not Just Smart Access

Now is the time to double down on:

• AI-powered detection algorithms that flag anomalies in real time
• Retrospective audits that focus on high-risk service lines (think: inpatient rehab, ED, DME)
• Clinical validation tools that assess medical necessity post-service
• Crosswalks between prior auth data and claims outcomes to identify patterns of abuse

The very solutions we’ve written about — from MS-DRG integrity to short-stay reviews to DME validation — are no longer optional. They’re the new frontline.

Final Thought: Reform Without Guardrails Is Just Risk Repackaged

Prior authorization reform is a step forward for patient access. But without a corresponding investment in oversight infrastructure, it could become a backdoor for waste, fraud, and abuse.

Hospitals and payers alike must recognize: the future of integrity isn’t about saying “no” up front — it’s about knowing what happened after “yes.”